Cholecystokinin octapeptide improves cardiac function by activating cholecystokinin octapeptide receptor in endotoxic shock rats

World Journal of Gastroenterology

Volumn 11, Issue 22, 2005, Pages 3405-3410

  Zhao, Xiao Yun ^a,b   Ling, Yi Ling ^c   Li, Yu Guang ^a   Meng, Ai Hong ^c   Xing, Han Ying ^c  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b Hebei Provincial Key Laboratory of Aquatic Environment   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Endotoxic shock; Sulfated cholecystokinin octapeptide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; MESSENGER RNA; PROGLUMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; GENE EXPRESSION; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART RATE; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPTIC SHOCK; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 21044446527     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i22.3405     Document Type: Article

References (31)

1. Forfia PR, Zhang X, Ochoa F, Ochoa M, Xu X, Bernstein R, Sehgal PB, Ferreri NR, Hintze TH. Relationship between plasma NOx and cardiac and vascular dysfunction after LPS injection in anesthetized dogs. Am J Physiol 1998; 274: H193-201
2. Ling YL, Huang SS, Wang LF, Zhang JL, Wan M, Hao RL. Cholecystokinin octapeptide reverses experimental endotoxin shock. Acta Physiol Sin 1996; 48: 390-394
3. Ling YL, Cong B, Gu ZY, Li SJ, Zhou XH. Inhibitory effect of cholecystokinin octapeptide on pulmonary arterial hypertension during endotoxic shock. Zhongguo Xueshu Qikan Wenzhai 2000; 6: 890-892
4. Zhao XY, Ling YL, Shan BE, Meng AH, Zhang JL. Effect of cholecystokinin octapeptide on rat cardiac function and its receptor mechanism. Acta Physiol Sin 2002; 54: 239-243
5. Wank SA. Cholecystokinin receptors. Am J Physiol 1995; 269 (5 Pt 1): G628-646
6. Monstein HJ, Nylander AG, Salehi A, Chen D, Lundquist I, Hakanson R. Cholecystokinin-A and cholecystokinin-B/gasterin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. Scand J Gastroenterol 1996; 31: 383-390
7. Crawley JN, Corwin RL. Biological actions of cholecystokinin. Peptides 1994; 15: 731-755
8. Marker JD, Roberts ML. Chronotropic actions of cholecystokinin octapeptide on the rat heart. Regul Pept 1988; 20: 251-259
9. Janssen PJJM, Gardiner SM, Compton AM, Bennett T. Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long Evans rats. Br J Pharmacol 1991; 102: 123-134
10. Gaw AJ, Hills DM, Spraggs CF. Characterization of the receptors and mechanisms involved in the cardiovascular actions of sSCCK-8 in the pithed rat. Br J Pharmacol 1995; 115: 660-664
11. Zhao XY, Ling YL, Shang ZL, Li Q, Yin JX, Tan GJ. Cholecystokinin octapeptide increases free intracellular calcium of guinea pig cardiomyocytes through activation of Ca(2+) channel and tyrosine kinase. Shengli Xuebao 2004; 56: 31-35
12. Guarini S, Bazzani C, Leo L, Bertolini A. Haematological changes induced by the intravenous injection of SCCK-8 in rats subjected to haemorrhagic shock. Neuropeptides 1988; 11: 69-72
13. Wang LF, Ling YL, Huang SS, Zhang JL, Wan M, Hao RL, Ding XY, Zuo JL. Clearance of cholecystokinin by lung duringnormal and endotoric shock. Zhongguo Bingli Shengli Zazhi 1996; 12: 571-574
14. Riepl R, Jenssen TG, Revhaug A, Burhol PG, Gierchksky KE, Lehnert P. Increase of plasma cholecystokinin by Escherichia coli endotoxin-induced shock in swine. Z Gastroenterol 1986; 24: 691-699
15. Cong B, Ling YL, Gu ZY, Wan JX, Yao YX. Effect of cholecystokinin octapeptide on lipopolysaccharide- induced increase of NF-κB activity in rat lung tissues (Abstract). Zhongguo Bingli Shengli Zazhi 2000; 16: 991
16. Li SJ, Cong B, Yan YL, Yao YX, Ma CL, Ling YL. Cholecystokinin octapeptide inhibits the in vitro expression of CD14 in rat pulmonary interstitial macrophages induced by lipopolysaccharide. Chin Med J 2002; 1159: 276-279
17. Noble F, Roques BP. CCK-B receptor: chemistry,molecular biology,biochemistry and pharmacology. Progress in Neurobiol 1999; 58: 349-379
18. Kulaksiz H, Arnold R, Goke B, Maronde E, Meyer M, Fahrenholz F, Forssmann WG, Eissele R. Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach. Cell Tissue Res 2000; 299: 289-298
19. Wank SA. G protein-coupled receptors in gastrointestinal physiology I. CCK receptors: an exemplary family. Am J Physiol 1998; 274(4 Pt 1): G607-613
20. Monstein HJ, Ohlsson B, Axelson J. Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines. Scand J Gastroenterol 2001; 36: 738-743
21. Clerc P, Leung-Theung-Long S, Wang TC, Dockray GJ, Bouisson M, Delisle MB, Vaysse N, Pradayrol L, Fourmy D, Dufresne M. Expression of CCK2 receptors in the murine pancreas: proliferation,transdifferentiation of acinar cells, and neoplasia. Gastroenterology 2002; 122: 428-437
22. Pagliocca A, Wroblewski LE, Ashcroft FJ, Noble PJ, Dockray GJ, Varro A. Stimulation of the gastrin-cholecystokinin(B) receptor promotes branching morphogenesis in gastric AGS cells. Am J Physiol Gastrointest Liver Physiol 2002; 283: G292-299
23. Okada N, Kubota A, Imamura T, Suwa H, Kawaguchi Y, Ohshio G, Seino Y, Imamura M. Evaluation of cholecystokinin, gastrin, CCK-A receptor, and CCK-B/gastrin receptor gene expressions in gastric cancer. Cancer Lett 1996; 106: 257-262
24. Fontana MG, Moneghini D, Villanacci V, Donato F, Rindi G. Effect of cholecystokinin-B gastrin receptor blockade on chemically induced colon carcinogenesis in mice: follow-up at 52 wk. Digestion 2002; 65: 35-40
25. Reubi JC, Schaer JC, Waser B. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 1997; 57: 1377-1386
26. Matsumori Y, Katakami N, Ito M, Taniguchi T, Iwata N, Takaishi T, Chihara K, Matsui T. Cholecystokinin-B/gastrin receptor: a novel molecular probe for human small cell lung cancer. Cancer Res 1995; 55: 276-279
27. Behr TM, Jenner N, Radetzky S, Behe M, Gratz S, Yucekent S, Raue F, Becker W. Targeting of cholecystokinin-B /gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin. Eur J Nucl Med 1998; 25: 424-430
28. Zhu CQ, Wang GH, Tang CR. Alteration of the concentration of both preprocholecystokinin and preproenkephalin mRNA after brain injury in rat: in situ hybridization study. Acta Academiae Medicinae Shanghai 1995; 22: 266-268
29. Van Bree L, Zhang F, Schiffmann SN, Halleux P, Mailleux P, Vanderhaeghen JJ. Homolateral cerebrocortical changes in neuropeptide and receptor expression after minimal cortical infarction. Neuroscience 1995; 69: 847-858
30. Konturek SJ, Konturek PC, Plonka A, Duda A, Sito E, Zuchowicz M, Hahn EG. Implication of gastrin in cyclooxygenase-2 expression in Helicobacter pylori infected gastric ulceration. Prostaglandins Other Lipid Mediat 2001; 66: 39-51
31. Brzozowski T, Konturek PC, Konturek SJ, Pajdo R, Drozdowicz D, Kwiecien S, Hahn EG. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves. Regul Pept 1999; 82: 19-33